The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Open accessAbstract
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome. Objective: We aimed to provide an evidence‐ and consensus‐based revision of the clinical diagnostic criteria for PSP. Methods: We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy‐confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2‐day meeting, and refined in three further Delphi rounds. Results: Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context‐dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features. Conclusions: Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Self-citationSTEELE, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,924
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I., Quinn, N., Sethi, K. D., Shults, C., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,009
Self-citationHauw, J.-J., Daniel, S. E., Dickson, D., Horoupian, D. S., Jellinger, K., Lantos, P. L., McKee, A., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 852
Self-citationClinicopathological and imaging correlates of progressive aphasia and apraxia of speech
Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awl078 · Cited by 689
Self-citationWilliams, D. R., de Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., Holton, J. L., Revesz, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 667
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
PSP Genetics Study Group, Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., Wang, L.-S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.859 · Cited by 603
Self-citationInvited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492
Boxer, A. L., Yu, J.-T., Golbe, L. I., Litvan, I., Lang, A. E., & Höglinger, G. U. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30157-6 · Cited by 485
Self-citationLitvan, I., Hauw, J. J., Bartko, J. J., Lantos, P. L., Daniel, S. E., Horoupian, D. S., McKee, A., Dickson, D., Bancher, C., Tabaton, M., et al. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199601000-00010 · Cited by 475
Self-citationClinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP
Josephs, K. A., Petersen, R. C., Knopman, D. S., Boeve, B. F., Whitwell, J. L., Duffy, J. R., Parisi, J. E., & Dickson, D. W. (2006) · Neurology · doi:10.1212/01.wnl.0000191307.69661.c3 · Cited by 455
Self-citationClinicopathological correlations in corticobasal degeneration
Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., Huang, E. J., Trojanowski, J. Q., Growdon, M. E., Jang, J. Y., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22424 · Cited by 434
Self-citationNeuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
Dickson, D. W. (1999) · Journal of Neurology · doi:10.1007/bf03161076 · Cited by 416
Self-citationLitvan, I., Mangone, C. A., McKee, A., Verny, M., Parsa, A., Jellinger, K., D'Olhaberriague, L., Chaudhuri, K. R., & Pearce, R. K. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.6.615 · Cited by 410
Self-citationDoes corticobasal degeneration exist? A clinicopathological re-evaluation
Ling, H., O'Sullivan, S. S., Holton, J. L., Revesz, T., Massey, L. A., Williams, D. R., Paviour, D. C., & Lees, A. J. (2010) · Brain · doi:10.1093/brain/awq123 · Cited by 394
Respondek, G., Stamelou, M., Kurz, C., Ferguson, L. W., Rajput, A., Chiu, W. Z., van Swieten, J. C., Troakes, C., al Sarraj, S., Gelpi, E., et al. (2014) · Movement Disorders · doi:10.1002/mds.26054 · Cited by 384
Self-citationRadiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Whitwell, J. L., Höglinger, G. U., Antonini, A., Bordelon, Y., Boxer, A. L., Colosimo, C., van Eimeren, T., Golbe, L. I., Kassubek, J., Kurz, C., et al. (2017) · Movement Disorders · doi:10.1002/mds.27038 · Cited by 260
Self-citationPure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy
Williams, D. R., Holton, J. L., Strand, K., Revesz, T., & Lees, A. J. (2007) · Movement Disorders · doi:10.1002/mds.21698 · Cited by 241
Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias
Lopez, O. L., Litvan, I., Catt, K. E., Stowe, R., Klunk, W., Kaufer, D. I., Becker, J. T., & DeKosky, S. T. (1999) · Neurology · doi:10.1212/wnl.53.6.1292 · Cited by 236
Self-citationKouri, N., Ross, O. A., Dombroski, B., Younkin, C. S., Serie, D. J., Soto-Ortolaza, A., Baker, M., Finch, N. C. A., Yoon, H., Kim, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8247 · Cited by 219
Self-citation18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
Passamonti, L., Vázquez Rodríguez, P., Hong, Y. T., Allinson, K. S. J., Williamson, D., Borchert, R. J., Sami, S., Cope, T. E., Bevan-Jones, W. R., Jones, P. S., et al. (2017) · Brain · doi:10.1093/brain/aww340 · Cited by 209
Self-citationJosephs, K. A., & Duffy, J. R. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283168ddd · Cited by 193
Self-citationPathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies
Marquié, M., Normandin, M. D., Meltzer, A. C., Siao Tick Chong, M., Andrea, N. V., Antón‐Fernández, A., Klunk, W. E., Mathis, C. A., Ikonomovic, M. D., Debnath, M., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24844 · Cited by 190
Accuracy of clinical diagnosis of progressive supranuclear palsy
Osaki, Y., Ben‐Shlomo, Y., Lees, A. J., Daniel, S. E., Colosimo, C., Wenning, G., & Quinn, N. (2004) · Movement Disorders · doi:10.1002/mds.10680 · Cited by 183
Self-citationCSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182
Self-citationFrontal presentation in progressive supranuclear palsy
Kaat, L. D., Boon, A. J. W., Kamphorst, W., Ravid, R., Duivenvoorden, H. J., & van Swieten, J. C. (2007) · Neurology · doi:10.1212/01.wnl.0000267643.24870.26 · Cited by 175
Self-citationLitvan, I. (1997) · Brain · doi:10.1093/brain/120.1.65 · Cited by 171
Self-citationWhich ante mortem clinical features predict progressive supranuclear palsy pathology?
Respondek, G., Kurz, C., Arzberger, T., Compta, Y., Englund, E., Ferguson, L. W., Gelpi, E., Giese, A., Irwin, D. J., Meissner, W. G., et al. (2017) · Movement Disorders · doi:10.1002/mds.27034 · Cited by 169
Self-citationAtypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration
Josephs, K. A., Katsuse, O., Beccano-Kelly, D. A., Lin, W.-L., Uitti, R. J., Fujino, Y., Boeve, B. F., Hutton, M. L., Baker, M., & Dickson, D. W. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000218446.38158.61 · Cited by 153
Self-citationRespondek, G., Roeber, S., Kretzschmar, H. A., Troakes, C., Al‐Sarraj, S., Gelpí, E., Gaig, C., Chiu, W. Z., Swieten, J. C. V., Oertel, W. H., et al. (2013) · Movement Disorders · doi:10.1002/mds.25327 · Cited by 149
Self-citationDevelopment and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration
Wood, E. M., Falcone, D., Suh, E. R., Irwin, D. J., Chen‐Plotkin, A. S., Lee, E. B., Xie, S. X., Deerlin, V. M. V., & Grossman, M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3956 · Cited by 146
Self-citationDistinctive Features of Saccadic Intrusions and Microsaccades in Progressive Supranuclear Palsy
Otero‐Millan, J., Serra, A., Leigh, R. J., Troncoso, X. G., Macknik, S. L., & Martínez‐Conde, S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2600-10.2011 · Cited by 143
Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study
Kanazawa, M., Shimohata, T., Toyoshima, Y., Tada, M., Kakita, A., Morita, T., Ozawa, T., Takahashi, H., & Nishizawa, M. (2009) · Movement Disorders · doi:10.1002/mds.22583 · Cited by 135
Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
Birdi, S., Rajput, A. H., Fenton, M. E., Donat, J. R., Rozdilsky, B., Robinson, C. A., Macaulay, R. J. B., & George, D. H. (2002) · Movement Disorders · doi:10.1002/mds.10211 · Cited by 135
Self-citationTsuboi, Y., Josephs, K. A., Boeve, B. F., Litvan, I., Caselli, R. J., Caviness, J. N., Uitti, R. J., Bott, A. D., & Dickson, D. W. (2005) · Movement Disorders · doi:10.1002/mds.20478 · Cited by 131
Self-citationWilliams, D. R., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.22977 · Cited by 131
Ling, H., de Silva, R., Massey, L. A., Courtney, R. J., Hondhamuni, G., Bajaj, N. P. S., Lowe, J. S., Holton, J. L., Lees, A. J., & Révész, T. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12037 · Cited by 97
Boeve, B. F., Dickson, D. W., Duffy, J. R., Bartleson, J. D., Trenerry, M. R., & Petersen, R. C. (2003) · European Neurology · doi:10.1159/000068502 · Cited by 82
Self-citationMochizuki, A., Ueda, Y., Komatsuzaki, Y., Tsuchiya, K., Arai, T., & Shoji, S. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0682-5 · Cited by 77
Hassan, A., Parisi, J. E., & Josephs, K. A. (2011) · Neurocase · doi:10.1080/13554794.2011.627345 · Cited by 76
Self-citationCerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C
Koga, S., Josephs, K. A., Ogaki, K., Labbé, C., Uitti, R. J., Graff‐Radford, N. R., van Gerpen, J. A., Cheshire, W. P., Aoki, N., Rademakers, R., et al. (2016) · Movement Disorders · doi:10.1002/mds.26499 · Cited by 76
Self-citationCompta, Y., Valldeoriola, F., TOLOSA, E. S., Rey, M. J., Martí, M. J., & Valls‐Solé, J. (2007) · Movement Disorders · doi:10.1002/mds.21612 · Cited by 63
Self-citationNagao, S., Yokota, O., Nanba, R., Takata, H., Haraguchi, T., Ishizu, H., Ikeda, C., Takeda, N., Oshima, E., Sakane, K., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.005 · Cited by 55
Kanazawa, M., Tada, M., Onodera, O., Takahashi, H., Nishizawa, M., & Shimohata, T. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.07.019 · Cited by 53
Iwasaki, Y., Mori, K., Ito, M., Tatsumi, S., Mimuro, M., & Yoshida, M. (2013) · Neuropathology · doi:10.1111/neup.12012 · Cited by 42
An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
Kurz, C., Ebersbach, G., Respondek, G., Giese, A., Arzberger, T., & Höglinger, G. U. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0391-7 · Cited by 32
Self-citationPure akinesia as initial presentation of PSP: A clinicopathological study
Facheris, M., Maniak, S., Scaravilli, F., Schüle, B., Klein, C., & Pramstaller, P. P. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.11.004 · Cited by 20
Sakamoto, R., Tsuchiya, K., & Mimura, M. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2009.01032.x · Cited by 17
Research works printed but not linked: 3
- 10.3988/jcn.2010.6.3.148 · doi:10.3988/jcn.2010.6.3.148
- Scottish Intercollegiate Guidelines Network, 2008, SIGN 50. A Guideline Developer's Handbook
- Boxer AL, Targeting tau therapeutics to PSP: support from new diagnostic criteria and biomarkers, Lancet Neurol
Cited by
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Self-citationJanelidze, S., Mattsson, N., Palmqvist, S., Smith, R., Beach, T. G., Serrano, G. E., Chai, X., Proctor, N. K., Eichenlaub, U., Zetterberg, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0755-1 · Cited by 1,247
Structure-based classification of tauopathies
Shi, Y., Zhang, W., Yang, Y., Murzin, A. G., Falcon, B., Kotecha, A., van Beers, M., Tarutani, A., Kametani, F., Garringer, H. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03911-7 · Cited by 878
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators, Thijssen, E. H., La Joie, R., Wolf, A., Strom, A., Wang, P., Iaccarino, L., Bourakova, V., Cobigo, Y., Heuer, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0762-2 · Cited by 761
Self-citationTau PET imaging in neurodegenerative tauopathies—still a challenge
Leuzy, A., Chiotis, K., Lemoine, L., Gillberg, P.-G., Almkvist, O., Rodriguez-Vieitez, E., & Nordberg, A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0342-8 · Cited by 628
Metadata
- Authors
- Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., Arzberger, T., Englund, E., Gelpi, E., Giese, A., Irwin, D. J., Meissner, W. G., Pantelyat, A., Rajput, A., van Swieten, J. C., Troakes, C., Antonini, A., Bhatia, K. P., Bordelon, Y., Compta, Y., Corvol, J., Colosimo, C., Dickson, D. W., Dodel, R., Ferguson, L., Grossman, M., Kassubek, J., Krismer, F., Levin, J., Lorenzl, S., Morris, H. R., Nestor, P., Oertel, W. H., Poewe, W., Rabinovici, G., Rowe, J. B., Schellenberg, G. D., Seppi, K., van Eimeren, T., Wenning, G. K., Boxer, A. L., Golbe, L. I., Litvan, I., & for the Movement Disorder Society–endorsed PSP Study Group
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2017-05-03
- Volume
- 32
- Issue
- 6
- Pages
- 853-864
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2623663856
- Cited by
- 2,359
- References
- 48
- FWCI
- 91.27
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- CurePSP
- National Institutes of Health (R01‐NS89757, R01‐DC12519, P01‐AG017586, P50‐NS053488, P30‐AG010124)
- Medical Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.